Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 4, keine Gesamtzahl für „below“
Suchtreffer
Begriffe & Kennungen
Atosiban SUN · 4.3 · - Gestational age below 24 or over 33 completed weeks - Premature rupture of the membranes >30 weeks of gestat
Eintrag öffnenAtosiban SUN · 4.3 · Atosiban must not be used in the following conditions: - Gestational age below 24 or over 33 completed weeks -
Eintrag öffnenAtosiban SUN · 4.8 · The frequency of adverse reactions listed below is defined using the following convention: very common (≥1/10)
Eintrag öffnenAtosiban SUN · 4.8 · The frequency of adverse reactions listed below is defined using the following convention: very common (≥1/10)
Eintrag öffnenAubagio · 4.8 · Listed below are the adverse reactions reported with AUBAGIO in placebo-controlled studies in adult patients,
Eintrag öffnenAubagio · 4.8 · Mild increases in transaminase, ALT below or equal to 3-fold ULN were more frequently seen in teriflunomide-tr
Eintrag öffnenAvastin · 4.8 · Adverse reactions are added to the appropriate frequency category in the tables below according to the highest
Eintrag öffnenAvonex · 4.8 · *Class label for interferon beta products (see section 4.4). ┼ Class label for interferon products, see below
Eintrag öffnenAvonex · 4.8 · *Class label for interferon beta products (see section 4.4). ┼ Class label for interferon products, see below
Eintrag öffnenAwiqli · 4.8 · Adverse reactions listed below are based on clinical trial data and classified according to MedDRA System Orga
Eintrag öffnenAxumin · 4.8 · Adverse reactions were reported commonly (≥ 1/100 to < 1/10) during clinical studies. They are listed below by
Eintrag öffnenAxura · 4.8 · The following Adverse Reactions listed in the Table below have been accumulated in clinical studies with Axura
Eintrag öffnenAxura · 4.8 · The following Adverse Reactions listed in the Table below have been accumulated in clinical studies with Axura
Eintrag öffnenAzacitidine Mylan · 4.8 · Table 1 below contains adverse reactions associated with azacitidine treatment obtained from the main clinical
Eintrag öffnenAzarga · 4.8 · AZARGA is not recommended for use in children and adolescents below 18 years due to a lack of data on safety a
Eintrag öffnenAzilect · 4.8 · Adjunct Therapy The tabulated list below includes adverse reactions which were reported with a higher incidenc
Eintrag öffnenAzilect · 4.8 · Adverse reactions are listed below in Tables 1 and 2 by system organ class and frequency using the following c
Eintrag öffnenAzilect · 4.8 · Monotherapy The tabulated list below includes adverse reactions which were reported with a higher incidence in
Eintrag öffnenBaiama · 4.8 · The safety data described below include all adverse reactions from the eight phase III studies in the indicati
Eintrag öffnenBaiama · 4.8 · The safety data described below include all adverse reactions from the eight phase III studies in the indicati
Eintrag öffnen